Our Mission
We're redefining how Male LUTS/BPH and OAB are diagnosed and treated
Today's Challenge
Lower urinary tract symptoms (LUTS) affect a growing group of patients. Nearly 80 million adults in the U.S. and over 90 million in the EU. Symptoms such as urgency, frequency, and difficult urination are often caused by benign prostatic hyperplasia (BPH) or overactive bladder (OAB).
Problem & Impact
Only 20%-50% of individuals are diagnosed and even fewer receive effective therapy. Current diagnostic methods are inaccurate, uncomfortable and time-consuming while conservative therapeutic options for Male LUTS/BPH and OAB remain limited.
Solution
Minze’s platform integrates digital diagnostics and therapeutic solutions for male LUTS/BPH and OAB, combining both in-clinic and home-based uroflowmetry, automated bladder diaries, and digital therapeutics. It provides clinicians with accurate insights through the Minze clinician portal, enabling informed diagnosis and personalized treatment at scale.
Our Promise
Accurate, In-Clinic & Home Diagnostics.
Scalable, Digital Therapies.
Time efficiency.
